검색
Abcellera Biologics Inc
ABCL관심 목록에 추가
5.715USD
+0.025+0.44%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
1.74B시가총액
손실P/E TTM
자세한 내용은 Abcellera Biologics Inc 회사
AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. It is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two internal programs, ABCL635 and ABCL575, are in late-preclinical studies. ABCL635 is an antibody drug candidate for metabolic and endocrine conditions, and ABCL575 is an antibody drug candidate with broad potential in inflammatory conditions and autoimmune diseases and an initial indication in atopic dermatitis. ABCL575 binds OX40L to disrupt OX40/OX40L signaling, a regulator of inflammatory pathways in AD. In addition to ABCL635 and ABCL575, it is advancing a pipeline of more than 20 internal discovery programs.
Abcellera Biologics Inc 정보
종목 코드 ABCL
회사 이름Abcellera Biologics Inc
상장일Dec 11, 2020
CEOHansen (Carl L.G)
직원 수596
유형Ordinary Share
회계 연도 종료Dec 11
주소150 W 4Th Avenue
도시VANCOUVER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Canada
우편 번호V5Y 1G6
전화16045599005
웹사이트https://www.abcellera.com/
종목 코드 ABCL
상장일Dec 11, 2020
CEOHansen (Carl L.G)
Abcellera Biologics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Veronique Lecault, Ph.D.
Dr. Veronique Lecault, Ph.D.
Co-Founder, Chief Operating Officer, Director
Co-Founder, Chief Operating Officer, Director
9.61M
--
Mr. Andrew Booth
Mr. Andrew Booth
Chief Financial Officer
Chief Financial Officer
576.56K
+43.36%
Dr. Carl L.G. Hansen, Ph.D.
Dr. Carl L.G. Hansen, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
--
--
Mr. Tryn T. Stimart, J.D.
Mr. Tryn T. Stimart, J.D.
Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer
Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer
--
--
Dr. Michael R. Hayden
Dr. Michael R. Hayden
Lead Independent Director
Lead Independent Director
--
--
Mr. John S. Montalbano
Mr. John S. Montalbano
Independent Director
Independent Director
--
--
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Quake
Mr. Stephen Quake
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Veronique Lecault, Ph.D.
Dr. Veronique Lecault, Ph.D.
Co-Founder, Chief Operating Officer, Director
Co-Founder, Chief Operating Officer, Director
9.61M
--
Mr. Andrew Booth
Mr. Andrew Booth
Chief Financial Officer
Chief Financial Officer
576.56K
+43.36%
Dr. Carl L.G. Hansen, Ph.D.
Dr. Carl L.G. Hansen, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
--
--
Mr. Tryn T. Stimart, J.D.
Mr. Tryn T. Stimart, J.D.
Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer
Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer
--
--
Dr. Michael R. Hayden
Dr. Michael R. Hayden
Lead Independent Director
Lead Independent Director
--
--
Mr. John S. Montalbano
Mr. John S. Montalbano
Independent Director
Independent Director
--
--
자주 묻는 질문
Abcellera Biologics Inc의 상위 5대 주주는 누구인가요?
Abcellera Biologics Inc의 상위 5대 주주는 다음과 같습니다: Dr. Veronique Lecault, Ph.D.
Abcellera Biologics Inc(ABCL)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Abcellera Biologics Inc의 주식을 보유한 기관은 총 323곳이며, 이들이 보유한 주식의 총 가치는 약 131.69M로 전체 발행 주식의 43.14%를 차지합니다. 이는 2025Q4 대비 -19217264.00 증가한 수치입니다.
Abcellera Biologics Inc의 최대 수익원은 무엇인가요?
2026Q1 기준, Abcellera Biologics Inc의 Licensing revenue 부문이 가장 높은 매출을 기록했으며, 금액은 46.92M로 전체 매출의 62.45%를 차지했습니다.